About us

Life Science Invest Fund 1 (LSIF1) was established in July 2023. Recognizing the current difficult market conditions for raising capital, it is our aim to support predominately late stage and commercial stage companies within medtech and biotech with capital.

We are long term investors, and we prefer to work closely together with the companies in structuring financing rounds, and to explore, if we can assist the companies in any other way.

The normal investment size per round will be up to SEK 10 mio.

We offer to participate as:

• Guarantor
• Investor in direct issues
• Investor in rights issues

Please contact Jan Poulsen at jp@lsif.dk for further information.